全文获取类型
收费全文 | 31003篇 |
免费 | 2479篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 427篇 |
儿科学 | 830篇 |
妇产科学 | 674篇 |
基础医学 | 4012篇 |
口腔科学 | 389篇 |
临床医学 | 3220篇 |
内科学 | 6488篇 |
皮肤病学 | 564篇 |
神经病学 | 2742篇 |
特种医学 | 1515篇 |
外国民族医学 | 1篇 |
外科学 | 4904篇 |
综合类 | 457篇 |
一般理论 | 40篇 |
预防医学 | 2446篇 |
眼科学 | 535篇 |
药学 | 2225篇 |
中国医学 | 35篇 |
肿瘤学 | 2075篇 |
出版年
2023年 | 314篇 |
2022年 | 584篇 |
2021年 | 1184篇 |
2020年 | 664篇 |
2019年 | 989篇 |
2018年 | 1122篇 |
2017年 | 759篇 |
2016年 | 811篇 |
2015年 | 991篇 |
2014年 | 1289篇 |
2013年 | 1636篇 |
2012年 | 2363篇 |
2011年 | 2409篇 |
2010年 | 1288篇 |
2009年 | 1030篇 |
2008年 | 1642篇 |
2007年 | 1665篇 |
2006年 | 1564篇 |
2005年 | 1409篇 |
2004年 | 1295篇 |
2003年 | 1078篇 |
2002年 | 1041篇 |
2001年 | 475篇 |
2000年 | 403篇 |
1999年 | 386篇 |
1998年 | 232篇 |
1997年 | 188篇 |
1996年 | 183篇 |
1995年 | 148篇 |
1994年 | 133篇 |
1993年 | 117篇 |
1992年 | 305篇 |
1991年 | 271篇 |
1990年 | 257篇 |
1989年 | 222篇 |
1988年 | 212篇 |
1987年 | 228篇 |
1986年 | 239篇 |
1985年 | 201篇 |
1984年 | 163篇 |
1983年 | 130篇 |
1982年 | 116篇 |
1981年 | 107篇 |
1979年 | 126篇 |
1978年 | 96篇 |
1974年 | 92篇 |
1973年 | 120篇 |
1972年 | 100篇 |
1970年 | 93篇 |
1969年 | 96篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
BACKGROUND: We reviewed the publication record of all protocols submitted to the Capital District Health Authority Research Ethics Board (REB) in Halifax, Nova Scotia, for the period 1995-1996. Because of a heightened awareness of the issue, we hypothesized that there would be less publication bias (a failure to report negative results) and a higher publication rate from completed studies, than previously reported. METHODS: Closed studies were identified from the REB database. Publications were identified by the investigators, requests from sponsors, and a literature review. For each publication, we identified authors, title, journal, number of subjects enrolled, and whether or not the publication was a report of a randomized clinical trial. Comparisons were done using a Student's t test, the Chi-square statistic, or Fisher's exact test as appropriate. RESULTS: From the database of closed studies, 106 remained unpublished, while completed investigations resulted in 84 publications (44% publication rate). The median time to publication was 32.5 months. Publication of statistically significant results occurred in 71/84 trials. Publication of protocols submitted by departments ranged from 91% (anesthesia; 10/11) to 25% [nursing; 2/8 (P<0.05)]. Trials investigating new drugs in Phase 3 or 4 studies were more likely to be published than trials investigating agents in Phase 1 or 2 (P<0.05), and were less likely to be published if sponsored by a pharmaceutical company (P<0.05). CONCLUSIONS: Publication bias continues to be a problem, particularly for early phase investigative studies. Our results suggest that a different approach is required to reduce publication bias. The role that REBs and peer-reviewed journals might play requires further exploration. 相似文献
53.
54.
Steven N Singh X Charlene Tang Bramah N Singh Paul Dorian Domenic J Reda Crystal L Harris Ross D Fletcher Satish C Sharma J Edwin Atwood Alan K Jacobson H Daniel Lewis Becky Lopez Dennis W Raisch Michael D Ezekowitz 《Journal of the American College of Cardiology》2006,48(4):721-730
OBJECTIVES: The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF. BACKGROUND: Restoration of SR in patients with AF improving QOL and EP remains controversial. METHODS: Patients with persistent AF were randomized double-blind to amiodarone, sotalol, or placebo. Those not achieving SR at day 28 were cardioverted and classified into SR or AF groups at 8 weeks (n = 624) and 1 year (n = 556). The QOL (SF-36), symptom checklist (SCL), specific activity scale (SAS), AF severity scale (AFSS), and EP were assessed. RESULTS: Favorable changes were seen in SR patients at 8 weeks in physical functioning (p < 0.001), physical role limitations (p = 0.03), general health (p = 0.002), and vitality (p < 0.001), and at 1 year in general health (p = 0.007) and social functioning (p = 0.02). Changes in the scores for SCL severity (p = 0.01), functional capacity (p = 0.003), and AFSS symptom burden (p < 0.001) at 8 weeks and in SCL severity (p < 0.01) and AF symptom burden (p < 0.001) at 1 year showed significant improvements in SR versus AF. Symptomatic patients were more likely to have improvement. The EP in SR versus AF was greater from baseline to 8 weeks (p = 0.01) and to 1 year (p = 0.02). The EP correlated with physical functioning and functional capacity except in the AF group at 1 year. CONCLUSIONS: In patients with persistent AF, restoration and maintenance of SR was associated with improvements in QOL measures and EP. There was a strong correlation between QOL measures and EP. 相似文献
55.
The effect of low dose lofepramine in depressed elderly patients in general medical wards. 下载免费PDF全文
R S Tan R J Barlow C Abel S Reddy A J Palmer A E Fletcher C G Nicholl B M Pitt C J Bulpitt 《British journal of clinical pharmacology》1994,37(4):321-324
A double-blind randomised controlled trial of the effect of low dose lofepramine (70 mg once daily) against placebo was carried out on depressed elderly inpatients on general medical wards for the elderly, comparing measures of depression and side-effects between the randomised groups. Patients were identified for the study using the Geriatric Depression Scale (GDS) and the Brief Assessment Schedule Depression Cards (BASDEC). Sixty-three subjects were randomised: 46 patients completed the entire trial of 28 days treatment. BASDEC and GDS were administered on day 8 post-admission, and depressed patients were randomised double-blind to either low dose lofepramine (70 mg daily) (n = 23) or placebo (n = 23). Assessment of changes in depressive states were made using the Montgomery Asberg Depression Rating Scale (MADRS) on days 8, 18 and 36 post-admission. Both groups improved by a similar amount during the trial. Lofepramine tended to be more effective than placebo in those patients who were more depressed (GDS > or = 18). On the other hand, subjects who were less depressed (i.e. GDS < 18) improved more on placebo than lofepramine. Low dose lofepramine may prove useful in moderately or severely depressed patients treated for only 4 weeks. However, low dose lofepramine is not indicated for mild (GDS 15-18) depression. 相似文献
56.
57.
John D Scott Janet A Englund David Myerson Adam P Geballe 《Journal of clinical virology》2004,31(2):96-99
BACKGROUND: Stem cell transplant recipients are susceptible to pulmonary infections, including influenza A. Typically, isolated influenza pneumonia has a diffuse, interstitial infiltrate pattern. OBJECTIVES: To describe the unusual clinical and radiographic course of influenza A pneumonia in a stem cell transplant recipient. STUDY DESIGN: Case report in which microbiologic assays, bronchoscopic and pathologic specimens are obtained. RESULTS: We describe a patient with influenza A pneumonia 8 months following a peripheral blood stem cell transplant who presented with minimal respiratory symptoms and rapidly progressing, focal pulmonary infiltrates. The large size and appearance of the masses have not been reported before in a patient with isolated influenza. CONCLUSION: This case highlights the differences of presentation and importance of early diagnosis and treatment of immunocompromised patients infected with influenza. 相似文献
58.
59.
60.
Conjunctivitis and pterygium associated with the American Indian type of polymorphous light eruption 总被引:1,自引:0,他引:1
D C Fletcher K G Romanchuk P R Lane 《Canadian journal of ophthalmology. Journal canadien d'ophtalmologie》1988,23(1):30-33
We describe three patients with the American Indian type of polymorphous light eruption (actinic prurigo), two Cree Indian sisters and a Cree Indian boy, who had eye symptoms similar to those seen in limbal-type vernal catarrh. 相似文献